We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Functional Eyeglasses Reduce Digital Eye Strain

By HospiMedica International staff writers
Posted on 04 Aug 2015
A new class of functional eyewear is designed to combat eye strain caused by the blue light emitted from digital devices, including computer screens and smartphones. More...


The Jins Screen lenses are designed to reduce transmission of light in the 460 nm range by 25% via two pathways: coating and substrate. Certain wavelengths of blue light are reflected by the patented coating on the lenses, while others are absorbed by the substrate. A clinical study conducted at Keio University (Tokyo, Japan) in 2011 showed a significant difference in the decrease of critical flicker frequency (CFF), an index used to measure eye strain, when the glasses were worn.

Originally launched as JINS PC in Japan, over five million pairs have been sold so far. Jins (Tokyo, Japan) will start selling the Screen glasses on August 8, 2015, in the US Several different options are available; boxed Jins Screen are non-prescription, and come in eight different colors and two styles, the Square and the Wellington. Jins will also offer Screen technology on its prescription glasses, available as an extra coating on any of its 1,200 frames and lenses, for an additional cost.

“Our goal is to improve people’s lifestyles with glasses, by making them less about vision correction and more about changing the way people perceive the world around them. That is why we continue to introduce new functional eyewear like Jins Screen,” said Hitoshi Tanaka, CEO of Jin. “I hope that these innovations are only the beginning for eyewear. We’re so excited to be able to change the course of the industry and can’t wait to see what happens next.”

With the advent of blue light-emitting LEDs, illuminated screens on devices, and an increase in late-night working hours, consumers today are exposed to more artificial blue light in the 380–500 nanometer range than ever before. Although blue light is essential for the regulation of the body’s circadian rhythm, the digital generation is exposed to too much blue light, resulting in considerable eye strain.

Related Links:

Jins
Keio University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Pedicle Screw Platform
CREO DLX Stabilization System
New
Mattress System
Apollo Infant Dynamic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.